Decheng Capital Global Life Sciences Fund IV, L.P. 13D and 13G filings for :
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-24 4:16 pm Purchase | 2025-02-14 | 13G | Aardvark Therapeutics, Inc. Common Stock AARD | Decheng Capital Global Life Sciences Fund IV, L.P. | 3,917,299 18.300% | 3,917,299 (New Position) | Filing |